Kardigan, a heart health company modernizing cardiovascular drug development, announced positive Phase 2 data on ataciguat in patients with moderate calcific aortic valve stenosis, presented today in ...

The heart can be compared to a water pump that does not stop working, and the four "gates of the heart" — the mitral, ...

PARTNER 3 may notch a win for transcatheter aortic valve replacement in patients with low surgical risk, according to experts ...

Low-risk patients with severe, symptomatic aortic stenosis show similar clinical outcomes and valve durability ...

More than 10 million older adults in the U.S. have mild or greater valvular heart disease and the prevalence is expected to grow over the next several decades, according to data from the PREVUE-VALVE ...

People living with aortic stenosis (AS) could gain earlier access to innovative care and treatment thanks to a new effort ...

People living with aortic stenosis (AS) could gain earlier access to innovative care and treatment thanks to a new effort from the American Heart Association designed to boost clinical trial ...

Acute pulmonary embolism is a life-threatening condition because it places sudden strain on the right ventricle of the heart.

Seven-year follow-up data show that transcatheter aortic-valve replacement (TAVR) and surgical aortic-valve replacement have similar clinical outcomes for low-risk patients with severe, symptomatic ...

People living with aortic stenosis (AS) could gain earlier access to innovative care and treatment thanks to a new effort ...

in patients with severe calcific aortic stenosis and to support a future PMA submission. “We are extremely pleased to receive FDA approval for the PARADIGM Trial, which allows us to commence patient ...

PARADIGM: A Prospective rAndomized tRial Assessing the safety and effectiveness of the DurAVR® bIomimetic valve designed for physioloGic flow compared to CoMmercial TAVR devices MINNEAPOLIS and ...